Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Torrent Pharmaceuticals Limited

Healthcare IN TORNTPHARM

4335.3999INR
-33.1001(0.76%)

Last update at 2026-06-04T09:48:00Z

Day Range

4328.104425.00
LowHigh

52 Week Range

2880.984104.80
LowHigh

Fundamentals

  • Previous Close 4368.50
  • Market Cap1362716.66M
  • Volume564972
  • P/E Ratio63.48
  • Dividend Yield-%
  • EBITDA39478.20M
  • Revenue TTM122480.90M
  • Revenue Per Share TTM361.87
  • Gross Profit TTM 92701.90M
  • Diluted EPS TTM63.43

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax 26728.10M 23521.10M 18470.00M 12259.10M 15262.60M
Minority interest 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Net income 19110.00M 16563.80M 12450.00M 7771.80M 12518.80M
Selling general administrative 7382.20M 7722.80M 6137.60M 5548.80M 5794.00M
Selling and marketing expenses 12606.70M 11296.80M 10269.90M 8849.10M 7426.30M
Gross profit 87401.90M 80416.30M 67290.00M 58813.30M 56509.30M
Reconciled depreciation 7950.00M 8080.00M 7070.00M 6620.00M 6580.00M
Ebit 29260.60M 25723.50M 21800.00M 19536.30M 18673.20M
Ebitda 36758.20M 33249.00M 28870.00M 26155.60M 25251.10M
Depreciation and amortization 7497.60M 7525.50M 7070.00M 6619.30M 6577.90M
Non operating income net other - - - - -
Operating income 58883.50M 54979.90M 21400.20M 17693.40M 18227.70M
Other operating expenses 56277.40M 52298.50M 73290.00M 66494.60M 60578.60M
Interest expense 2520.00M 3535.60M 3330.00M 2529.30M 3561.60M
Tax provision 7620.00M 6960.00M 6020.00M 4490.00M 2740.00M
Interest income 2310.70M 114.80M 3330.00M 2550.00M 3580.00M
Net interest income -2520.00000M -3540.00000M -3330.00000M -2550.00000M -3580.00000M
Extraordinary items - - - - 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 7615.60M 6957.30M 6020.00M 4487.30M 2743.80M
Total revenue 115160.90M 107278.40M 94640.00M 84188.00M 78862.30M
Total operating expenses 28518.40M 25436.40M 45940.00M 41119.90M 38225.60M
Cost of revenue 27759.00M 26862.10M 27350.00M 25374.70M 22353.00M
Total other income expense net -32155.40000M -31458.80000M -2928.60000M -5434.30000M -2965.10000M
Discontinued operations - - - - -
Net income from continuing ops 19110.00M 16560.00M 12450.00M 7770.00M 12520.00M
Net income applicable to common shares 19112.50M 16563.80M 12450.00M 7771.80M 12518.80M
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 149900.00M 150605.80M 150120.00M 130998.40M 140746.50M
Intangible assets 42630.00M 45828.20M 50890.00M 35460.60M 39840.30M
Earning assets - - - - -
Other current assets 5240.00M 4841.10M 3030.00M 3120.00M 4510.00M
Total liab 73990.00M 82044.30M 88140.00M 71468.90M 82374.80M
Total stockholder equity 75910.00M 68561.50M 61980.00M 59529.50M 58371.70M
Deferred long term liab - - - - -
Other current liab 10330.00M 8097.30M 1030.00M 990.00M 1280.00M
Common stock 1690.00M 1692.30M 1690.00M 846.20M 846.20M
Capital stock 1690.00M 1690.00M 1690.00M 846.20M 846.20M
Retained earnings 47465.50M 39424.00M 33031.90M 29166.80M 28064.70M
Other liab - - - 5717.60M 3825.90M
Good will 3390.00M 3380.30M 3380.00M 2594.80M 3412.30M
Other assets 6217.30M 5821.70M 5436.70M 6848.00M 5293.00M
Cash 5790.00M 8351.40M 5080.00M 3984.00M 5725.60M
Cash and equivalents 2315.20M 3992.90M 379.80M 228.10M 149.30M
Total current liabilities 47170.00M 54252.50M 54470.00M 44150.90M 48916.20M
Current deferred revenue - 45.00M 8460.00M 7320.40M 7859.50M
Net debt 26230.00M 31868.00M 48600.00M 36712.50M 43015.70M
Short term debt 18640.00M 23537.00M 28190.00M 19096.10M 19108.60M
Short long term debt 18340.00M 23340.00M 28010.00M 18950.00M 7040.00M
Short long term debt total 32020.00M 40219.40M 53680.00M 40696.50M 48741.30M
Other stockholder equity -2504.90000M 714.30M 27258.10M 29516.50M 29460.80M
Property plant equipment 38229.10M 35777.70M 34598.40M 32469.30M 36287.50M
Total current assets 56230.00M 56114.80M 53140.00M 51649.90M 55215.00M
Long term investments - - - - -
Net tangible assets - - - 21474.10M 15119.10M
Short term investments 1144.90M 1410.00M 3270.00M 1845.50M 1654.50M
Net receivables 18670.00M 18443.00M 19460.00M 18077.20M 16512.90M
Long term debt 11920.00M 16040.00M 24960.00M 21230.00M 29410.00M
Inventory 25410.00M 22790.70M 22300.00M 24623.20M 26812.00M
Accounts payable 18200.00M 20893.20M 16790.00M 16744.40M 20668.10M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 26749.10M 27445.20M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 8859.40M 3233.50M 1958.90M 3208.10M 1093.60M
Deferred long term asset charges - - - - -
Non current assets total 93670.00M 94491.00M 96980.00M 79348.50M 85531.50M
Capital lease obligations 1760.00M 840.00M 710.00M 520.00M 486.70M
Long term debt total 13376.10M 16682.40M 25491.50M 21600.00M 29632.70M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -5400.00000M -1680.00000M -24150.00000M -80.90000M -1206.50000M
Change to liabilities - - - -4576.70000M 1295.20M
Total cashflows from investing activities -5400.00000M -1679.00000M -24150.00000M -1966.30000M -4494.20000M
Net borrowings -9255.00000M -13694.40000M - -8464.40000M -9562.90000M
Total cash from financing activities -22980.00000M -27796.40000M 770.00M -17810.50000M -16561.30000M
Change to operating activities - - - - -
Net income 19110.00M 16563.80M 18470.00M 12259.10M 15262.60M
Change in cash -2621.40000M 3266.10M 1100.00M -1741.60000M -892.60000M
Begin period cash flow 8351.40M 5085.30M 3980.00M 5725.60M 6618.20M
End period cash flow 5730.00M 8351.40M 5080.00M 3984.00M 5725.60M
Total cash from operating activities 25850.00M 32660.80M 23680.00M 18029.90M 20106.90M
Issuance of capital stock - - - - -
Depreciation 7950.00M 7953.00M 7070.00M 6619.30M 6577.90M
Other cashflows from investing activities 74.60M 1467.80M -18410.00000M 72.40M 52.50M
Dividends paid 10830.00M 10153.40M -8630.00000M -6768.90000M -3384.50000M
Change to inventory -2620.00000M -490.00000M 2560.00M 2188.80M -5329.80000M
Change to account receivables 171.70M 780.00M -2897.20000M -1091.10000M 652.10M
Sale purchase of stock - - - - -
Other cashflows from financing activities -2895.00000M -3948.60000M 19120.00M -711.80000M 1202.20M
Change to netincome - - - 7157.30M 4397.50M
Capital expenditures 6110.00M 4327.80M 5740.00M 2025.70M 3351.50M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -4809.30000M 45.30M -180.00000M -3518.50000M -3382.50000M
Stock based compensation - - - - -
Other non cash items 3599.30M 8098.70M -1680.00000M 2670.00M 1648.90M
Free cash flow 19740.00M 28333.00M 17940.00M 16004.20M 16755.40M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (INR) Price (INR) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TORNTPHARM
Torrent Pharmaceuticals Limited		 -33.1001 0.76% 4335.40 63.48 56.50 11.13 16.39 11.65 35.91
SUNPHARMA
Sun Pharmaceutical Industries Limited		 -7.0 0.39% 1781.50 40.32 26.95 7.69 5.50 7.41 23.64
DIVISLAB
Divi's Laboratories Limited		 21.00 0.32% 6597.50 70.47 - 17.47 11.44 17.33 47.08
CIPLA
Cipla Limited		 24.70 1.80% 1399.90 21.74 19.01 4.23 3.76 4.08 14.00
DRREDDY
Dr. Reddy's Laboratories Limited		 4.90 0.39% 1268.20 17.16 21.93 2.94 2.89 2.99 10.39

Reports Covered

Stock Research & News

View All

Profile

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Torrent Pharmaceuticals Limited

Torrent House, Ahmedabad, India, 380009

Key Executives

Name Title Year Born
Mr. Samir Uttamlal Mehta Exec. Chairman & MD 1964
Mr. Jinesh Shah B.Sc., MBA Exec. Director of Operations & Whole Time Director 1977
Mr. Sudhir Menon CA, CWA Exec. Director of Fin. & CFO 1972
Mr. Chintan Trivedi Company Sec. & Compliance Officer NA
Mr. Abdullah Salam Said Al Abri Chief Customer Service Officer NA
Mr. R. Chandrashekhar Inter CA VP of Procurement 1969
Jaydip Bhatt VP of Human Resource 1953
H. L. Guttikar B.E., MMS VP of Projects 1963
Ashish Hajarnish M.Pharm VP of Works 1968
Hasmukh Patel B.Pharm, M.Pharm. VP of Works 1968

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions